ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 262

$537K Total Retail Price of All Prescriptions

Rank: 15 out of 262

637 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 637 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LISINOPRIL 583 550 1 3
LEVOTHYROXINE SODIUM 554 507 2 2
SIMVASTATIN 524 465 3 1
HYDROCHLOROTHIAZIDE 493 450 4 7
FUROSEMIDE 465 443 5 4
AMLODIPINE BESYLATE 408 396 6 6
METOPROLOL TARTRATE 396 352 7 8
OMEPRAZOLE 365 295 8 5
METOPROLOL SUCCINATE 252 231 9 11
POTASSIUM CHLORIDE 241 224 10 10
METFORMIN HCL 212 187 11 9
SERTRALINE HCL 201 198 12 14
ATENOLOL 189 187 13 16
WARFARIN SODIUM 185 185 14 12
CRESTOR 163 161 15 30
JANTOVEN 150 145 16 39
TRAMADOL HCL 128 113 17 18
TAMSULOSIN HCL 125 118 18 25
ATORVASTATIN CALCIUM 117 114 19 13
GABAPENTIN 117 102 19 19
DONEPEZIL HCL 109 109 21 23
CLOPIDOGREL 106 91 22 38
HUMALOG 102 75 23 100
ALLOPURINOL 100 100 24 22
LOSARTAN POTASSIUM 99 98 25 17
CEPHALEXIN 93 86 26 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 75 27 24
LANTUS SOLOSTAR 90 90 28 49
LANTUS 85 47 29 51
ALENDRONATE SODIUM 83 69 30 21
DIGOXIN 80 76 31 28
ISOSORBIDE MONONITRATE ER 79 61 32 33
CARVEDILOL 79 61 32 31
CITALOPRAM HBR 74 53 34 20
NAMENDA 72 67 35 37
PANTOPRAZOLE SODIUM 68 68 36 52
ACETAMINOPHEN-CODEINE 68 66 S3 36 108
HYDROCODONE-ACETAMINOPHEN 67 60 S3 38 15
GLIPIZIDE 67 67 38 70
LACTULOSE 64 64 40 131
FENTANYL 64 64 S2 40 40
AGGRENOX 63 62 42 140
TRIAMCINOLONE ACETONIDE 62 61 43 105
PRAVASTATIN SODIUM 62 53 43 41
DIOVAN 61 61 45 47
PREDNISONE 61 59 45 29
PEN NEEDLE 59 53 47 108
PLAVIX 58 53 48 64
FLUOXETINE HCL 56 35 49 46
DILTIAZEM ER 55 43 50 75
SPIRONOLACTONE 54 32 51 58
PROAIR HFA 53 48 52 53
INSULIN SYRINGE 53 43 52 85
TRIAMTERENE-HCTZ 52 52 54 32
NOVOFINE AUTOCOVER 51 51 55 219
NITROSTAT 51 49 55 219
FELODIPINE ER 50 50 57 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.